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INTRODUCTION 
The discovery of Helicobacter pylori in 1982 by Marshall & Warren118 
was the starting point of a revolution concerning the concepts and management 
of gastroduodenal diseases. H.pylori is a gram negative curved motile rod 
found in the deeper portion of the mucous gel coating the gastric mucosa. It is 
extraordinary among bacteria in its ability to colonize and persist among this 
niche for decades despite host defenses and gastric acidity. 
It is now established that H.pylori infection induces several gastro 
intestinal complications, ranging from mild gastritis to peptic ulcers 85 and even 
gastric malignancies, such that the International Agency for Research on 
Cancer38 has declared this pathogen as an independent carcinogen. In addition 
the etiologic association of this infection with an increasing number of 
disorders including cardiovascular diseases27, and metabolic syndrome113 are 
being investigated. Therefore it is of utmost essence to detect the infection and 
pursue with eradication therapy and follow up. 
Several diagnostic modalities are available to detect H.pylori infection. 
The two major categories of diagnostic assays are endoscopic or invasive tests 
and non endoscopic or non invasive tests. The endoscopy based tests include 
rapid urease, histopathological evaluation, polymerase chain reaction and 
culture. The non-endoscopic tests include antibody detection methods and 
carbon labeled urea breath test. The choice of the tests depends on the 
laboratory resources and the clinical situation whether for diagnosing infection 
or for documenting eradication. 
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H.pylori is a robust producer of urease and its presence is detected by 
rapid urease tests. The advantage of these tests is that they can be readily 
performed in the endoscope suite. Another rapid test is smear evaluation of the 
specimen. Imprint smears stained by rapid Giemsa or Gram stain provide an 
adjuvant to histopathological examination of gastric biopsy specimens.    
Culture is probably the most difficult approach to the diagnosis of 
H.pylori. The advantages are that it is highly specific and the antibiotic 
sensitivity can be detected. High rate of false negatives due to the fastidious 
nature of the organism coupled with expense incurred for culture have limited 
its application. 
Chronic H.pylori infection elicits local and systemic immune response 
that lead to production of antibodies. The presence of IgG antibodies to 
H.pylori can be detected by immunoassays.  Serology is sensitive for primary 
diagnosis but is not useful in assessing post treatment H.pylori status58.   
The urea breath test relies on the urease activity of H.pylori to detect the 
presence of infection. Sensitivity is excellent because the whole stomach is 
sampled. Unlike serology it is useful for determining the success of the 
eradication therapy. Even though the test is more accurate than serology its 
usage is limited due to high cost and lack of facilities for testing. 
With the advent of PCR, many possibilities have emerged for 
diagnosing H.pylori infection. PCR allows identification of the organism in 
samples with few bacteria and.it has been successfully used to detect H.pylori 
CagA and VacA virulence genes in gastric biopsy samples100. PCR is being 
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evaluated for its utility in identifying H.pylori in samples of dental plaque, 
saliva and other easily sampled tissues. The potential advantage of PCR 
includes high specificity, quick results and the ability to identify different 
strains of bacteria for pathogenic and epidemiologic studies. The major 
limitation of PCR is that relatively few laboratories currently have the capacity 
to run the assay.      
In the present study, four parameters, namely rapid urease test, culture 
method, histopathology, and serology were used to detect presence of H.pylori 
in the gastric biopsy samples, supplemented with PCR for selected 50 samples. 
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REVIEW OF LITERATURE 
Historical perspective68 
 The presence of gastric spiral bacteria was first reported in 1893.Spiral 
bacteria were demonstrated for the first time, in the human stomach in 1906. In 
1924 the presence of urease activity in the human stomach was documented. 
The bacterial source of gastric urease was confirmed in 1968. Bacteria were 
reported in association with gastritis in 80% of gastric resection specimens 
from patients with gastric ulceration. 
           The modern era was heralded in 1981 when Barry Marshall, began a 
clinical research project with Robin Warren, in the Royal Perth Hospital, 
Western Australia. Subsequent attempts to culture these bacilli were 
unsuccessful until April 1982 when during the Easter weekend, the plates were 
unintentionally incubated for 5 days and colonies were visible.  
     The association of these bacteria with gastritis was first presented at the 
Royal Australian College of Physicians on 22 October 1982 and published in 
letter form in 1983.  
 These 'Campylobacter'-like organisms' were called Campylobacter 
pyloridis. For grammatical reasons, the name was changed to Campylobacter 
pylori in 1987. Subsequently, it was shown that C pylori did not belong to the 
genus Campylobacter and a new genus name was suggested in 198965.  
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          The association with peptic ulceration, and possibly with gastric 
adenocarcinoma, was initially suggested by Marshall et al 67. 
         Reliable diagnostic techniques which facilitated epidemiological and 
interventional studies, such as serology, the rapid urease test, and the [13C] and 
[14C] urea breath tests soon became available. 
       A group of specialists with an interest in the infection, the European H. 
pylori Study Group, was formed in Copenhagen in 1987 and this was followed 
by an exponential increase into the study of the role of the bacteria in gastro 
duodenal diseases. The first long-term clinical trial of treatment aimed at 
eradicating H. pylori in patients with duodenal ulceration was reported in 1987. 
        The relationship between the organism and gastric adenocarcinoma and 
MALT (gastric mucosa-associated lymphoid tissue) lymphoma was reported in 
1991.  
       Subsequent studies assessed the role of the organism in gastro-
oesophageal reflux disease, patients receiving long-term acid suppressing 
medication, paediatric populations, and non-ulcer dyspepsia. 
         In 1994, H. pylori was recognized as a grade I (definite) carcinogen and 
the National Institutes of Health Consensus Development Conference 
Statement recommended that all patients who are found to have gastric or 
duodenal ulceration and concurrent H. pylori infection should receive treatment 
aimed at eradicating the bacterium81.  
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     In 1997, it was 'strongly recommended' by a European consensus panel 
that patients with H.pylori infection and peptic ulcer, low grade mucosa-
associated lymphoid tissue lymphoma, severe macroscopic or microscopic 
gastritis or recently resected early gastric cancer should receive a proton pump 
inhibitor-based triple therapy to eradicate the infection. 
Definition of genus 
 Helicobacters are helical, S-shaped or curved gram-negative rods, 0.5-
1.0 µm wide by 2.5-5.0µm long. Motility is rapid and darting by means of 
single or multiple unipolar, bipolar, or lateral sheathed flagella. Cells exposed 
to air may form coccoid bodies. They are non-sporing and micro-aerophilic 
with respiratory metabolism. They are non-saccharolytic, oxidase-positive and 
catalase-positive, except for Helicobacter canis which is catalase-negative 29.  
Habitat 
 The surface of the human stomach mucosa is the major habitat of H. 
pylori.  Its natural niche appears to be the mucous- lined surface of the non-
acid-secreting area close to the pyloric sphincter, i.e., the antrum3.  
 Almost all isolations are from gastric biopsy specimens, but the 
organism has occasionally been detected in gastric juices, saliva, dental 
plaque50, bile and faeces.  
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Morphology112 
 H. pylori cells take the form of curved, or S-shaped gram-negative rods, 
0.5-0.9 µm wide by about 3 µm long with a wavelength of about 2.6 µm. In 
agar cultures spiral forms are less obvious and cells appear more as singly 
curved rods. H pylori undergo coccal transformation on exposure to air within 
1-2 hr at room temperature, and in this state it fails to grow on subculture 112. 
Such coccoid forms do not appear to be virulent (Eaton et al. 1995).                
 By electron microscopy, the organism is spiral with bluntly rounded 
ends and with 4-8 sheathed, unipolar, flagella; the sheath is continuous with the 
outer membrane of the cell wall. Some flagella have a terminal bulb. A 
glycocalyx-like material surrounding the cell is also apparent. 
Cultural Characteristics and Growth Requirements   
 H. pylori are strictly micro-aerophilic, requiring C02 (5-20%) and high 
humidity for growth. H. pylori require media containing supplements such as 
blood, haemin, serum, starch or charcoal. Growth is best on media such as 
moist freshly prepared heated (chocolated) blood agar, or brain-heart infusion 
agar with 5% horse blood and 1% IsoVitaleX. 
 Strains grow in various liquid media supplemented with fetal calf or 
horse serum (Shahamat et al. 1991). Some strains grow in serum-free media, 
notably bisulphite-free brucella broth (Hawrylik et al. 1994).  All strains grow 
at 37°C, some grow poorly at 30°Cand 42°C [18] but none grows at 25°C. 
Colonies from primary cultures at 37°C usually take 3-5 days to appear and are 
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circular, convex and they seldom grow bigger than 2 mm in diameter even if 
incubation is extended beyond 1 week.  
 They are weakly hemolytic on 5% horse blood agar. Motility is weak or 
absent when grown on agar. H. Pylori are inactive in most conventional 
biochemical tests. Notable exceptions are the strong production of urease71,  
catalase 67  and alkaline phosphatase. All strains produce DNAase, leucine 
aminopeptidase, and glutamylaminopeptidase (McNulty and Dent 1989)72. 
GENETICS 
  H.pylori has a small genome of about 1700 kb. It is so genetically 
diverse that, usually, any 2 independent isolates can be distinguished by a 
variety of genetic analyses, and ribotyping H.pylori reveals the presence of two 
copies of 16S rRNA gene which helped in the classification of the organism.  
        The presence of virulence genes in H.pylori plays a major role in the 
clinical outcome. CagA pathogenicity island is associated with increased 
incidence of peptic ulcer19 and adenocarcinoma 12.The VacA gene is seen in all 
H.pylori strains has been associated with increased gastric damage10.  
      VacAs1 and vacAs2 code for toxigenic and non toxigenic types 
respectively Other important genes are babA1,babA2 and babB which code for 
adhesion molecule,flagellin genes flaA and flaB,iceA1 a gene for restriction  
endonuclease, OipA  that codes for a protein which induces IL-8 and, genes 
ureA,ureB,E,F,G that code  for urease 21. 
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Cell Wall Composition And Antigenic Structure112 
 Helicobacters have the typical cell wall structure of gram-negative 
bacteria. The fatty acid profile of H. pylori is distinctive and is characterized by 
long-chain fatty acids composed predominantly of tetrade-canoic (14:0) and 
19-carbon cyclopropane (19:0 cyc) acids (Moran 1995). 
 H. Pylori contain at least 4 outer-membrane proteins ranging from 48 to 
67 kDa that have pore-forming ability. The various strains share the same 
lipopolysaccaride core antigens but differ in their side chain antigens. 
Susceptibility to antimicrobial agents59 
 H. Pylori is sensitive to penicillins,(including benzylpenicillin) 
cephalosporins, tetracycline, erythromycin, rifampicin, amino glycosides and 
nitro furans, but resistant to nalidixic acid, though sensitive to the more active 
quinolones such as ciprofloxacin. H. pylori is usually susceptible to 
metronidazole, and are sensitive to colloidal bismuth compounds commonly 
prescribed for gastric disease in concentrations easily attainable in the stomach. 
The proton pump inhibitor omeprazole has mild in vitro activity against H 
pylori; 1% bile salts are also inhibitory. 
Epidemiology of Helicobacter 
Infectious dose 
 Data concerning infectious dose78 come from the first successful 
volunteer infection, in which a dose of 109 organisms in a small liquid feed was 
used. 
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 It is difficult to judge whether the natural infectious dose of H. pylori is 
large or small. Animal models, especially in primates, and related studies with 
other Helicobacter26 might help to fill this gap in our knowledge. 
Spread from an animal reservoir or by foods 
 H. pylori is found in cats36 and could be a reservoir for human infection 
25 but  neither a zoonotic reservoir nor food as a vehicle appear to be 
significantly involved in acquisition of H. pylori. 
Spread by water 
 Though examples among children in Peru, South America suggest a role 
for water as a vehicle, it does not project it as a main route of acquisition 52 & 5. 
Spread by fomites 
 Restriction enzyme analysis of bacterial DNA demonstrated individuals 
infected with identical strains, out breaks of achlorhydria in the U.S and acute 
mucosal lesion syndrome in Japan are examples of iatrogenic H.pylori 
infection transmitted by endoscope114. 
Spread by direct contact 
 The major modes of transmission of H. pylori are still uncertain, 
although oral-oral, gastro-oral, and faecal-oral routes are all  possibilities11 . 
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 There have been suggestions that the mouth may be a reservoir for  
re-infection, even though samples are often apparently culture negative32. It is 
also possible that re-infection may occur by person-to-person transmission 
between spouses102.  
 A study showed that a physician became infected with H. pylori after 
giving mouth-to-mouth resuscitation to an H. pylori positive patient who had 
recently vomited24. It has been suggested that gastro-oral transmission may be 
common in children. 
       Several reports relate to spread from a faecal source. The organism has 
been cultured from faeces111, and also has been detected in faeces by PCR. 
Variation in the age of acquisition of H pylori infection  
 The age of acquisition of H. pylori shows marked geographical variat-
ion. Among children acquisition appears most frequent under 15 years of age20, 
rates of acquisition in adult life is between 1% and 3% per annum 95. 
Other risk factors for infection 
 Low levels of socio-economic status and education are associated with 
an increase in prevalence of H. pylori infection109. It is possible that 
consumption of alcohol, may relate to seropositivity. Clustering of infection 
within families has been commonly, but not uniformly, observed22. High rates 
of seropositivity in children are found in many developing countries. 
Seroprevalence of H. pylori infection is often similar in males and females22. 
Several studies found no increased risk of infection in dentists62 although 
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Increased H. pylori seropositivity has been noted in gastroenterologists31 and 
endoscopists. 
Risk of re- infection 
 Many reports define a cut off time, using a minimum period of 4 weeks 
after treatment, the interval after which they would use the word reinfection. It 
is probable that many ‘re-infections' represent recrudescence after treatment 
failure. Treatment failures were overwhelmingly due to the persistence of the 
same strain119. 
Estimations of a disease to infection ratio for Helicobacter pylori – 
associated peptic ulcer disease 
 A disease-to-infection ratio can be estimated for India, where H. pylori 
seroprevalence is high96. An endoscopic study45  found a point prevalence of 
active peptic ulceration of 4.7% and, if duodenal deformity was included as 
evidence of previous disease, 11% of the population had had peptic ulcer 
disease, a lifetime disease risk in infected individuals of 13%.In immigrant 
monks in South India who neither smoked nor used NSAIDs, the point 
prevalence of active ulcer disease was 6.6%, the lifetime prevalence (including 
scarring) was 13.2%, and the lifetime disease-to-infection ratio was estimated 
at 16%, with a disease-to-infection point prevalence ratio of 8%. 
 Although the prevalence of peptic ulcer disease varies between 
populations and over time and began to decline before antibiotic or antacid 
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treatments became common place, the available data suggest that 6-20% of 
untreated H. pylori infections will lead to peptic ulcer disease. 
Pathogenesis of Clinical Syndromes40 
H pylori gastritis is associated with several important pathologic 
conditions including:- 
• Duodenal ulcer disease  
• Gastric ulcer disease  
•  Gastric adenocarcinoma arising from the distal stomach.  
• Gastric lymphoma  
Duodenal ulcer disease 
Approximately 90% of patients who have duodenal ulceration have H. 
pylori infection. Several characteristics are found more commonly in ulcer-
associated than in non-ulcer-associated H. pylori strains. The two best 
characterized are presence of the Cag (cytotoxin-associated gene) 
pathogenicity island, and production of an active vacuolating cytotoxin Vac A. 
The Cag pathogenicity island is a genetic region containing over 30 genes. The 
island encodes a type IV secretory apparatus, best thought of as a syringe, 
through which one Cag-encoded protein, CagA, is 'injected' into epithelial 
cells. CagA induces the epithelial cell to undergo several changes including the 
secretion of pro-inflammatory cytokines, which leads to increased gastric 
inflammation. CagA is also highly immunogenic and anti-CagA antibody 
detection can be used as a serum test for the presence of the island. 
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The vacuolating cytotoxin, VacA, is a pore-forming toxin that increases 
epithelial permeability and causes massive epithelial cell vacuolation in vitro. 
However, only some VacA genotypes are associated with the toxigenic 
phenotype and infection with strains of certain VacA genotypes is associated 
with increased prevalence of peptic ulcer disease. 
 There has been considerable recent research into other virulence factors 
include an adhesin, BabA, a bacterial outer membrane proinflammatory 
protein, OipA, and a restriction enzyme, Ice A, and its associated methylase. 
Other bacterial factors are also thought to be important for pathogenesis in 
terms of colonization and the induction of inflammation, such as the enzyme 
urease and the ability to adhere to gastric mucosa. 
Gastric ulcer disease 
H pylori associated gastric ulcers usually arise in junctional mucosa 
between antral and corpus type tissues, typically on the lesser curvature. They 
usually occur in patients with pan-gastritis rather than antral-predominant 
gastritis and are not associated with increased stimulated acid output. Their 
pathogenesis is uncertain, but infection with virulent strains and smoking 
increase risk. 
Gastric adenocarcinoma 
The World Health Organization has classified H. pylori as a type 1 or 
causal carcinogen. It is a risk factor for distal adenocarcinoma with a relative 
risk of 4-9. Distal gastric adenocarcinoma usually arises in patients with pan-
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gastritis.  Both Cag+ and cytotoxic strains are more likely to be associated with 
carcinoma than other strains. Host genetics are also important; people with 
genetic polymorphisms that lead to high-level secretion of the proinflammatory 
cytokine interleukin-1 in response to bacterial infection are more likely to 
develop gastric cancer. Intestinal-type gastric cancer is thought to occur by a 
step-wise process from superficial gastritis through atrophy to intestinal 
metaplasia, dysplasia and ultimately carcinoma. 
Gastric Lymphoma 
 Primarily gastric lymphomas arise in lymphoid tissue present in the  
H.Pylori infected stomach. When histologically low grade, the majority regress 
following H. pylori eradication. 
The reason for H.pylori mediated duodenal ulceration remains unclear. 
One potential explanation is that gastric metaplasia in the duodenum of 
Duodenal ulcer patients permits H. pylori to bind to it and produce local injury 
secondary to the host response. 
H. Pylori antral infection could lead to increased acid production, 
increased duodenal acid, and mucosal injury. H Pylori infection might induce 
increased acid secretion threw both direct and indirect actions of H. pylori and 
proinflammatory cytokines (IL-8, TNF, and IL-1) on G, D, and pariteal cell. In 
summary, the final effect of H. pylori on the gastrointestinal tract is variable 
and determined by microbial and host factors. 
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The type and the distribution of gastritis correlate with the ultimate 
gastric and duodenal pathology observed. Specifically, the presence of antral-
predominant gastric is associated with Duodenal Ulcer formation; gastritis 
involving primary the corpus predisposes to the development of Gastric Ulcer, 
gastric atrophy, ultimately Gastric carcinoma. 
CLINICAL FEATURES 
Acute H.pylori infection                          
 The clinical features of acute infection in the community are unknown. 
Upper abdominal discomfort and pain occurred 3 days after voluntary 
dosing107, followed by vomiting and finally a resolution of symptoms by the 
end of the week. Helicobacter pylori are most commonly acquired in 
childhood, but whether initial colonization is usually symptomatic or 
asymptomatic is not known. 
Chronic H.pylori infection                          
Chronic Helicobacter pylori infection is characterized by chronic active 
gastritis, but this condition is asymptomatic. Chronic infection therefore only, 
manifest symptomatically if complications develop, such as duodenal 
ulceration, gastric ulceration or gastric cancer. 
Laboratory Diagnosis  
The two major categories of diagnostic assays for H.pylori are 
endoscopic, or invasive, tests and nonendoscopic, or noninvasive test. 
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 Diagnostic test Method of organism Identification 
Invasive  Rapid urease test  by urease production 
 Histology by morphologic features and 
location 
 Culture by biochemical properties  
 Polymerase  chain 
reaction 
 by  genetic sequencing  
Noninvasive  Antibody detection  by immunologic response  
 Urea breath test  by  urease production 
 
Invasive Tests 
The stomach is usually accessed by fiber optic endoscopy, and biopsy 
specimens are obtained. Using two contrast stains, topical acriflavine and 
intravenous fluorescein, with a confocal laser endomicroscope, endoscopists 
were able to detect see clusters H. pylori on the surface and in the deeper layer 
of the gastric epithelium 53. This technique enabled detection of by surface 
microscopy imaging of living tissue during ongoing endoscopy for the first 
time. 
       It is possible that gastric juice obtained by a nasogastric tube allows the 
detection of H. pylori by culture, staining, urease test, and PCR, but it is less 
reliable than gastric biopsy specimens. The string test can also be used to 
obtain gastric mucus92; however, the most attractive method seems to be an 
extendable oro-gastric brush contained in a plastic tube. The brush is 
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swallowed, extended into the stomach to brush the mucosa three or four times, 
retracted in the protective sleeve, and withdrawn from the patient. This method 
is rapid and appears to be reliable for H. pylori infection diagnosis 34. 
Specimen Collection. 
The best specimens to culture H. pylori are biopsy samples obtained 
during endoscopy. The recommendation is not to consume Proton pump 
inhibitor for 2 weeks prior to endoscopy. 
Transport of  biopsy specimens. 
H. pylori are a fragile organism. and must be protected from desiccation 
and contact with oxygen and room temperature. It is mandatory to place them 
either in a saline solution for short-term transport (4 h maximum)76 or in a 
transport medium, usually consisting of semisolid agar, maintained at 4°C. A 
commercially available medium, Porta-germ pylori is effective for this purpose 
51. Storage at 4°C in a medium containing 20% glycerol also led to H. pylori 
recovery in 81% of the biopsy specimens tested 35 
Grinding of biopsy specimens. 
Comparison of culture performed with and without grinding showed a 
higher number of colonies after grinding, for this reason grinding of the biopsy 
specimen is mandatory32.    
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Media  
The media components include an agar base, growth supplements and 
selective supplements. Most agar bases are satisfactory for growing H. pylori, 
e.g., brain heart infusion agar, Columbia agar. Concerning the growth 
supplement, it is mandatory to add blood or serum, which includes numerous 
nutrients (vitamins and oligoelements, etc.) which enhance H.pylori growth.   
           The proportion of blood or serum can be 5%, 7%, or preferably, 10%. 
Red blood cells can be lysed for these growth substances to be more readily 
available. Animal blood, e.g., sheep or horse blood, can be added. Other 
growth supplements such as starch13, bovine serum albumin46 and 
Cyclodextrins, which are cyclic oligosaccharides produced from starch by 
enzymatic treatment retaining the same properties as starch, are employed86.  
Cellini et al, proposed a blood-free medium supplemented with 
isovitalex (2%) and hemin (10 mg/liter). They also added urea (20 g/liter) and a 
pH indicator (phenol red) to identify the urease-positive colonies15. H. pylori 
grow best at a slightly acidic pH (5 to 6), in agreement with its ecological 
niche, the mucus layer, where a pH gradient exists.  
        Another supplement which may be helpful to readily identify H. pylori 
colonies is 2, 3, 5-triphenyltetrazolium chloride (40 mg/liter). This compound 
is reduced by H. pylori to insoluble red formazan complexes, resulting in easily 
distinguished pigmented golden colonies. 
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       Different selective supplements containing antimicrobial compounds 
have been proposed: vancomycin or teicoplanin to inhibit gram-positive cocci; 
polymyxin, nalidixic acid, colistin, trimethoprim, or cefsulodin to inhibit gram-
negative rods; and nystatin or amphotericin B to inhibit fungi.  
Non selective media such as Chocolate agar, Brain heart infusion agar 
with 5% horse blood, Brucella agar with 5% Sheep blood and Tryptone Soya 
agar with 5% sheep blood can be used. Selective media59 include Skirrows 
Campylobacter Medium and Brain heart infusion agar with vancomycin 
[6ug/ml] nalidixic acid [20ug/ml] and amphotericin [2ug/ml] have given good 
recovery. 
Several studies performed in the early days of H. pylori detection 
showed the importance of using both a nonselective medium and a selective 
medium108. 
A critical point is to use fresh media (less than a week old) which is kept 
in closed boxes at 4°C to maintain humidity and avoid light exposure. 
Helicobacters are microaerophilic and capnophilic. Several systems can be 
used to achieve a microaerobic atmosphere, from the most sophisticated 
systems, such as a microaerobic cabinet or an incubator with an adjustable gas 
level, to jars in which the adequate atmosphere is created with an automatic 
apparatus or with H2-C02-generating packs.  
The atmosphere in jars will vary according to the quantity of bacteria 
consuming oxygen; therefore, the gas pack should be changed every other day. 
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While H. pylori growth is possible in a candle jar23, it takes a longer time and 
results in small colonies. 
The optimal culture temperature is 37°C, testifying to the adaptation of 
this bacterium to humans. For primary culture under optimal conditions, 
colonies may appear after 3 days and are at their optimum on day 4. However, 
in the case of negative culture, a 7- to 10-day incubation is recommended to 
ensure that the result is negative; if only a few organisms are present, this time 
lapse may be necessary to visualize the colonies. 
In contrast, subcultures only take 2 to 3 days. When few colonies are 
present, the recommendation is to subculture by plating the colonies on a small 
area of the agar plate. It is important to remember that once H. pylori reaches 
its growth plateau, it becomes coccoidal and loses its viability, most likely due 
to a lack of adequate nutrients. 
Broth culture.  
Brain heart infusion or Brucella Broth with 1-10% fetal calf serum59 
may be preferable for studies on physiology and metabolism.   
Identification of Helicobacter pylori in culture112 
The growth of small, circular, smooth grey and translucent colonies 
observed after 3 to 4 days on the selective media plated with gastric biopsy 
specimens is an important criterion for H. pylori identification. 
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Gram staining of the colonies reveals gram negative curved rods, the 
spiral forms being less obvious .The characteristic gull wing is seen in broth 
cultures. Motility is best demonstrated in broth cultures and is weak when 
grown on agar.  
The identification of culture consists essentially of testing for the 
presence of certain enzymes: cytochrome oxidase, catalase, and urease which 
are positive. 
The ApiCampy strip59 identification of H. pylori via positive urease, 
glutamyl transpeptidase, and alkaline phosphatase and negative nitrate 
reductase and hippuricase. Its resistance to nalidixic acid and sensitivity to the 
antibiotic  cephalothin, helps in distinguishing it from other species. 
Histopathological Diagnosis 1 
H.pylori can be identified with haemotoxylin and eosin but the bacteria 
can be more reliably seen with special stains1 such as acridine orange, modified 
Giemsa, cresyl violet or warthin-starry stains.  
The typical morphology of H.pylori is a comma shaped bacillus 
observed on the epithelial surface.  
Gram staining of the touch smear of the biopsy specimen by rubbing it 
forcefully on a glass slide was used to confirm the presence of Campylobacter 
pylori by Montgomery et al 198877 this method had a sensitivity and specificity 
of 92% and 100% respectively. 
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Nijhawan et al82 used the gastric crush cytology in the detection of 
H.pylori infection and highlighted the advantage of crush smears 
Warthin - Starry silver stain demonstrates H.pylori clearly as spiraled 
black rods against a yellow background. In Giemsa - stained sections, the 
organisms are clearly visible as Giemsa - positive (dark blue) spiraled rods. 
M. Anjana et al8, evaluated the staining method of impression smear by 
Gram, two-step Gram, dilute carbol-fuchsin and Giemsa.  
Urease Tests 
 The discovery that H. pylori are a strong urease producer was made by 
Langenberg et al55 and was used for rapid diagnosis by McNulty and Wise71. 
When a biopsy specimen containing H. pylori is introduced into a urea-rich 
medium, the urease hydrolyses the urea down into carbon dioxide and 
ammonia. The ammonium ion increases the pH, and a pH indicator, e.g., 
phenol red, changes color, in this case from yellow to red. 
Modifications include McNulty and Dent72 buffered 40% urea solution 
and Hazell’s37 solution with a high concentration of urea and pH indicator 
.Standardization of urease test was studied by Vinci. S .Jones et al. The various 
factors such as the concentration of urea in broth need for buffering the 
solution and addition of antibiotics were investigated 117. 
 A.V.Thillainayagam et al described the use of an ultra rapid endoscopy 
room test in which unbuffered urea solution with indicator was used. The test 
had a sensitivity and specificity of 89% and 100%110.  
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Commercial Kits  
The first-generation commercial kits were agar based, e.g., the CLO test. 
The new generation kits introduced in 1995 are strip-based tests 
 In the first study, Rogge et al 99,  compared this new test to the CLO test 
which showed 99% sensitivity and 95% specificity after 2 h, which is superior 
to those of the CLO test. 
Polymerase chain reaction2 [PCR] 
The PCR was developed in the 1980s and thereafter quickly applied to 
the detection of H. pylori. Its application in the field of H. pylori concerns not 
only the detection of the bacterium but also its quantification and detection of 
specific genes relevant to pathogenesis (CagA) and specific mutations 
associated with antimicrobial resistance. 
The first targets used were the genes of the urease operon: ureA and 
glmM, or the 16S rRNA gene.  
Two main pathogenic factors the Cag PAI and the polymorphism of the 
VacA gene and other genes involved in adherence (babA2, sabA) or in 
pathogenicity (oipA, dupA, iceA) can also be detected by PCR. The new real 
time PCR technique is considered a breakthrough as it allows quantification 
and detection of point mutation associated with antibiotic resistance. 
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NON- INVASIVE TEST  
The first method used was serology. However, due to the difficulty in 
obtaining an optimal specificity, other methods have been proposed namely 
Urea breath test, stool antigen test, and most recently, detection of specific 
antibodies in urine or saliva. 
Urea Breath Test [UBT] 66 
A solution of labeled urea ingested by the patient is rapidly hydrolyzed 
by H. pylori urease, the labeled C02 is absorbed by the blood and exhaled in 
expired air. If the patient is not infected, most of the isotope is eliminated in 
urine without modification. 
When [13C] urea is used, a specimen collection is performed before and 
30 min after the ingestion. 
The 13C/12C ratio is measured in both specimens, and the result is 
expressed as the difference between the two measurements. The need for a 
baseline value is due to the various amounts of 13C present in breath according 
to one's diet. When [14C] urea is used, specimen collection occurs only 20 min 
after ingestion. 
Stool Tests   
H. pylori culture from stools is not used as a routine diagnostic method.  
The first report of successful detection of H. pylori antigens in stools was made 
in 1997 by Kozak et al48 who reported an enzyme-linked immunosorbent assay 
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(ELISA) performed on stools this test was named H. pylori stool antigen test 
(HpSA). 
Serodiagnosis 
H. pylori infection is a chronic condition and immunoglobulin G (IgG) 
(subclasses 1 and 4) is the predominant immunoglobulin class, even in children  
IgG are present at the mucosal level and detected in virtually all blood samples. 
 IgM are rarely observed, merely because acute H. pylori infections are 
seldom available for study. 
In the experimental infection carried out by Morris et al78, an initial IgM 
response was observed. IgA are also elevated in the majority of infected cases 
but not in all. Therefore, as the relevance of IgM and IgA is limited, 
commercial kits are primarily designed to detect IgG. 
A complement fixation test was the first to be used in 1984 with 85% 
sensitivity41, but currently the standard ELISA and its derivatives, such as rapid 
immunoenzymatic assays and immunoblotting are being used. 
 The performance of an ELISA is largely dependent on the nature of the 
antigens used. The first antigens to be used were whole-cell sonicates. A partial 
purification to obtain surface antigens can be achieved by glycine acid 
extraction. ELISA’s with these complex antigens had a sensitivity of 95% with 
a specificity of 90% according to Newell and Rathbone84. Serological tests to 
detect CagA antibodies have also been designed based on recombinant 
proteins. 
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False-negative result may occur following a new infection before the 
antibody level is sufficiently elevated there also appears to be an increased 
prevalence of false negatives in the elderly. The very slow decrease in 
antibodies after eradication (25% in titer within 6 months or more) is also a 
cause of a false-positive result. 
For this reason, the tests detecting active infection are preferable. Recent 
data have shown that serology is the best method in difficult situations. 
Where bacterial density may be low due to gastric atrophy or due to 
previous treatment with Proton pump inhibitors or antibiotics, as is now 
frequently the case63. 
Development of point-of-care tests 
They are essentially based on the diffusion of antibodies from a drop of 
serum or whole blood obtained by finger puncture through a membrane and an 
immunoenzymatic reaction. The first test proposed had a very promising 
performance (sensitivity, 92%: specificity, 88%). However the point-of-care 
tests have not been recommended in the Consensus Conferences 81. 
Immunoblot analysis and detection of CagA antibodies. 
The immunoblot is most likely used as a second-step technique to 
identify false-positive cases detected by ELISA, in which case, the criteria 
proposed by Nillson83 et al must be used. A commercial immunoblot test is 
now available, which is an important advance towards standardization. 
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Detection of H. pylori antibodies in urine. 
Specific H. pylori IgG antibodies are eliminated in urine but at very low 
concentrations. Alemohammad et al6 presented the first data in 1993 using both 
ELISA and immunoblotting with good accuracy.   
Detection of H, pylori antibodies in saliva  
Detection of IgG antibodies is used by ELISA or by immunoblotting. 
Patel et al studied efficacy of various kits[89]. 
Treatment39 
The current recommended treatment for H. pylori eradication includes 
two antibiotics and an antisecretory drug, essentially a PPI, to which a bismuth 
salt can be added. The most commonly used association worldwide is a double 
dose of PPI (omeprazole, lansoprazole, pantoprazole, rabeprazole, or 
esomeprazole) plus clarithromycin (500 mg twice a day [b.i.d.]) and 
amoxicillin (1 g b.i.d.) for 7 days (treatment 1). Other 7-day regimens include a 
double dose of PPI plus clarithromycin (500 mg b.i.d.) and metronidazole (500 
mg b.i.d.) (Treatment 2) or a double dose of PPI plus amoxicillin (1 g b.i.d.) 
and metronidazole (500 mg b.i.d.) (Treatment 3), with the latter being mostly 
used as a second line treatment for 14 days in the case of failure of treatment 1. 
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The Antimicrobial Susceptibility 
Like any infectious agent59, H. pylori can acquire resistance to 
antimicrobial agents used to treat the infection, and therefore, susceptibility 
testing is important in the management of the infection.  
H.pylori is intrinsically resistant to glycopeptides, cefsulodin, 
polymyxins, nalidixic acid, trimethoprim, sulfonamides, nystatin, amphotericin 
B, and cycloheximide. Some of these are used as selective agents in isolation 
media. H. pylori acquire resistance by mutation. 
Susceptibility Testing Methods 
1. Phenotypic method 
(a) Agar dilution method: The agar dilution method, usually considered the 
reference method to compare other techniques, has been proposed by the 
Clinical Laboratory Standard Institute (CLSI) as the method to be used 
for H. pylori clarithromycin susceptibility testing80.  
(b) Broth dilution method: It has rarely been used for H. pylori because of 
the difficulty of growing, this bacterium in broth18.  
(c) Disk diffusion testing: The disk diffusion method is the simplest and 
most economic for susceptibility testing.  
(d) Etest: The latest method has the advantage of being a quantitative 
method with a direct expression of MICs, and furthermore, it is adapted 
to slow-growing bacteria like H. pylori. 
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Genotypic detection of resistance. 
H. pylori resistance is essentially due to chromosomal mutations which 
can be easily detected with molecular tests. Resistance to macrolides, 
fluroquinolones, tetracycline and metronidazole can be detected by RT-PCR. 
Fluroscent-in-situ-hybridization also has been used to detect clarithromycin 
resistance42. 
VACCINES4 
First evidence that protective immunization may, be a possibility came 
from Czinn and Nedrud in 1991. Urease was the early favorite vaccine 
candidate. Later both HspA and HspB protein were also shown to be 
immunogenic, Because of this and their apparent surface location, these 
proteins appeared as likely vaccine candidates. CagA and VacA are also being 
studied as vaccine candidates. Vaccine trails has been successful in animal 
models and studies are going on for a safe and effective vaccine. 
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AIMS OF THE STUDY 
1. Detection of Helicobacter pylori in outpatients and inpatients presenting 
with upper Gastrointestinal symptoms. 
2. To compare the various tests like Gram stain, Geimsa stain, Rapid 
urease, Culture and Histopathology for the identification of H.pylori. 
3. To find out the PCR positivity in gastric biopsy samples. 
4. To evaluvate the antibody response to H.pylori by 
Immunochromatography test and ELISA method. 
5. To correlate the H.pylori infection with Endoscopic clinical diagnosis. 
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MATERIAL AND METHODS 
ETHICAL CONSIDERATION 
The study was conducted with the approval from the institutional Ethical 
Committee Government General Hospital and Madras Medical College,  
Chennai-3. Permission to conduct the study was sought from the respective 
hospital authorities. Informed consent was obtained from the patients before 
the enrolment into the study. 
PERIOD OF STUDY 
This is a prospective cross sectional study conducted over a period of 
one year from April 2008 –   April 2009. 
PLACE OF STUDY 
This study was carried out at the Institute of Microbiology, Madras 
Medical College and Research Institute in collaboration with the Department of 
Medical Gastroenterology, Government General Hospital, Chennai.  
STUDY GROUP 
Outpatients and inpatients, of both sexes in the age group 20-69 years, 
based on the following criteria were included in the study. 
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Inclusion criteria: 
• Patients with complaints suggestive of upper gastro intestinal diseases.   
• Patients with gastric ulcer, duodenal ulcer, antral gastritis and gastric 
carcinoma. 
• Patients who were not on antibiotics, proton pump inhibitor or 
Helicobacter eradication therapy within 1 month prior to inclusion in 
this study. 
Exclusion criteria: 
• Patients with previous gastric surgery. 
• Patients with active bleeding56. 
STUDY DESIGN 
The details of complete history, clinical features of the patients to be 
subjected to endoscopy were obtained. Preinvasive procedure preparation for 
Oesophago-gastro-duodenoscopy was performed as per norms. Biopsy tissue 
was collected from the gastric antrum of the patient and the specimens were 
submitted for. Histopathological study, gram stain, culture, rapid urease test 
and PCR for identification of H pylori infection. A patient with Helicobacter 
pylori infection was defined as those patients who were positive for at least two 
out of the three evaluation tests. [Montgomery et al198877]; [Sengupta.S 2002-
92103]                     
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SPECIMEN COLLECTION AND TRANSPORT  
Biopsy Sample 
Patients fasted overnight before endoscopy. Endoscopy was done using 
fiber optic endoscope. The endoscope and the biopsy forceps were rinsed 
thoroughly with water and soaked in 2% gluteraldehyde for 20 minutes17 and 
were thoroughly rinsed with sterile normal saline just before the collection of 
specimen. 
       Five biopsy samples were taken from the antrum (2cm from the pylorus) 
and were transferred to respective Eppendroff tube under sterile conditions. 
One sample was inoculated into urea broth for rapid urease, two specimens 
were transported in normal saline for culture,  Gram stain and Giemsa stain, 
one in phosphate buffer saline for PCR and last specimen was placed in 10% 
formalin for histopathological examinations.The specimens for PCR were 
stored in phosphate buffer saline at -70 o C. 
         The specimens for culture were transported in ice to the laboratory and 
were inoculated on the culture media without delay. 
Blood 
3ml of venous blood was collected under aseptic precautions; serum was 
separated and stored at -20o c for further processing. 
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PROCESSING OF SPECIMENS 
Rapid Urease Test 64,117 
            An antral biopsy tissue was placed in an Eppendorf tube containing 0.5 
ml of freshly prepared 8% urea at a pH of 6.8 to which had been added two 
drops of 1% phenol red as a pH indicator. Colour change from yellow to red at 
room temperature within two hours, were taken as positive [Raul et al 2004] 98. 
Culture 93, 59, 23  
Biopsy  tissue  was  crushed  between two sterile glass slides  and the 
minced tissue was inoculated onto freshly prepared campylobacter agar base 
with 5% defibrinated sheep blood and Skirrows supplement (selective media) 
and  chocolate agar (non selective media).The plates were incubated at 37°C in 
a candle jar with a pad of cotton soaked in water placed at the bottom. The 
plates were examined for bacterial growth between three to seven days. 
Characteristic small, translucent circular colonies were confirmed by gram 
stain, catalase, oxidase and urease. They were sub cultured onto chocolate agar 
and campylobacter agar with skirrows supplement (Vancomycin 10 mg, 
PolymycinB 2500IU and Trimethoprim 5mg) till no growth was obtained. 
Confirmatory tests 49 for suspected colonies 
1. Gram stain-Gram negative curved bacilli were seen. 
2. Oxidase test-The suspected colony was streaked on the surface of 
oxidase strip containing 1% tetramethyl paraphenylene diamine 
dihydrochloride. An intense purple colour developed within 5 seconds 
and was recorded as positive. Positive and negative controls were used. 
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3. Urease test - The colony was emulsified in 0.5 ml of the urea broth. An 
instant colour change from yellow to pink was noted as positive. 
4. Catalase test - The suspected colony was introduced with a glass rod 
into 3% Hydrogen peroxide taken in a clean test tube. Immediate 
production of gas bubbles was noted as positive. Positive and negative 
controls were also tested. 
Crush cytology 82 
Another biopsy tissue was crushed between two sterile glass slides and 
the minced tissue was used to make to two smears. 
Gram stain   
One of the slides was air dried and heat fixed. The slide was covered 
with methyl violet for one minute, excess stain was poured off, Grams iodine 
was added and washed after 1 minute. This was followed by acetone for 2-3 
seconds. The acetone was washed and the slide was counter stained with dilute 
carbol fuschin for one minute, washed with water, blotted dry and observed 
under oil immersion objective. Helicobacter pylori appeared as gram negative 
curved bacilli. 
Giemsa stain   
The other slide was air dried and fixed with methanol for 3 minutes, 2-3 
drops of undiluted Giemsa stain was added and kept for 5 minutes. The smear 
was then washed with water, blotted dry and seen under oil immersion 
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objective. The organism appeared deep purple with the typical gull- wing 
morphology.  
Histopathology  
One specimen was fixed in 10% formalin, paraffin sections were made 
and stained with Haematoxylin and Eosin and examined for Helicobacter 
pylori. 
Serology 
The serological detection of IgG antibodies to cellular components of 
Helicobacter pylori was done using EURO IMMUN ELISA. The antigen 
coated in the wells  are  provided by the strain Lior 1 of Helicobacter pylori. 
The cultured bacteria have been disrupted in alkaline buffer. The antigen 
mixture used contains all significant proteins as verified by SDS 
polyacrylamide gel electrophoresis. 
Serology was done for 130 cases with gastro duodenal symptoms, 1 
positive control, 1 negative control and 3 calibrated standards were provided by 
the manufacturer. 
Methods 
Serum samples were diluted 1:101 before assay (10ul of serum was 
diluted with 1ml of sample diluent). 100ul of each calibrated standard or 
diluted sample was dispensed into the wells. The plate was incubated for 30 
minutes at room temperature. The wells were washed thoroughly thrice using 
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wash buffer. The micro plate was blotted on absorbent paper. 100ul conjugate 
consisting of rabbit anti human IgG conjugated with Horse radish peroxidase 
was added immediately into each well. The plate was incubated for 30 minutes 
at room temperature. 
Following incubation, the plate was washed 3 times with wash buffer. 
100ul of chromogen/substrate solution was added into each well. The plate was 
incubated for 15 minutes. Blue colour developed in the wells. 100ul of stop 
solution was added to each well in the same order as the chromogen substrate 
to allow equal reaction times. Blue colour changed to yellow on addition of the 
stop solution. The optical density was read at 450 nm in a microplate reader 
within 30 minutes of adding the stop solution.   
Calculation of results 
The optical density of each calibrator was plotted against its 
concentration and a curve was drawn through the points. The unknowns were 
read off the curve. 
Interpretation of results as per kit recommendations 
    Values below 16 Ru/ml-negative. 
    Values between16-22Ru/ml-intermediate. 
    Values above 22Ru/ml-positive. 
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One step antibodies to H. pylori test by SDBIOLINE H.pylori kit. 
The SDBIOLINE H. pylori test contains a membrane strip, which is pre-
coated with H. pylori capture antigen on test band region. The H. pylori antigen 
colloid gold conjugate and serum sample moves along the membrane 
chromatographically to the test region (T) and forms a visible line as the 
antigen –antibody-antigen gold particle complex forms with high degree of 
sensitivity and specificity. 
 The SDBIOLINE H. pylori test is a rapid test for the qualitative 
detection of antibodies of all isotypes (IgG, IgM, IgA, etc) specific to 
Helicobacter pylori in human serum, plasma or whole blood. 
Procedure  
1.  Remove the test device from the foil, and place it on a flat, dry surface. 
2. Transfer 10 µl of serum or plasma. Add 3 drops of assay diluent 
(approximately 110 µl) and start the timer. 
3. Interpret test results at 10 minutes. The result should not be interpreted 
after 10 minutes. 
Interpretation of the test: 
1. Negative Result: The presence of only one purple colour band 
within the result window indicates a negative result. 
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2. Positive Result: The presence of only two colour bands (“T” band 
and “C” band) within the result window, no matter which band 
appears fist, indicates a positive result. 
3. Invalid Result: If the purple colour band is not visible within the 
result window after performing the test, the result is considered 
invalid. 
DIAGNOSIS OF H. pylori INFECTION BY PCR. 
             In this study PCR was used to detect Helicobacter. Pylori by using 
primers specific for 16s rRNA gene. This gene is a highly specific target for 
amplification and has been previously used for reclassification of the 
organism98. 16s rRNA is targeted to confirm H.pylori infection and positive 
amplification of H.pylori specific DNA may be considered as a direct evidence 
of the presence of the pathogen. 100 
Preparation of samples for PCR amplification: 
50 gastric biopsy samples were chosen for PCR study. 50% of culture 
positive samples (11 out of 23) and 39 culture negative samples were processed 
for PCR detection for 16S rRna of H.pylori. The sample is homogenized in the 
DNA extraction solution [GeNei] TM. The genomic DNA is precipitated from 
the lysate with ethonol. Following an ethanol wash, DNA is solubilized in 
1xTE BUFFER. 
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The primer was derived from the region of the 16S rRna. 
Forward primer- 5’GCTAAGAGATCAGCCTATGTCC3’ 
Reverse primer- 5’TGGCAATCAGCGTCAGGTAATG3’ 
PCR Reaction Mixture Components: 
Components 
Final 
Concentration of 
reagents 
Quantity of 
reagents 
Template DNA 5-100 ng 1 μ L 
dNTP 2.5mM  1 μ L 
Buffer (10x) 1x 5 μ L 
F.R 20 pimol 0.4 μ m 1 μ L 
R.P 20 pimol 0.4 μ m 1 μ L 
Taq.Poly 2 μ 0.2 μ L 
MgCl2  2.5 mM 
D.W  40.3 μ L 
Total vol.  50 μ L 
 
The PCR tubes are mixed well and are kept in the thermo cycler and the target 
DNA were amplified as given in the table below.  
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PCR parameters: 
Operation Temperature Time in mins Cycle 
Initial Denaturation 95° C 5 1 
Denaturation 94° C 1 
39 Annealing 55° C 1 
Elongation 72° C 2 
Final Elongation 72° C 7  
 
The amplified PCR products were stored at 4° C until electrophoresis. 
Amplified products were run using horizontal 1.5% agarose gel 
electrophoresis. The gel was visualized using a UV trans illuminator. The 
amplified PCR products and 100 base pair DNA molecular markers were seen 
as bright fluorescent bands.  
Interpretation: 
 A 500 bp corresponds to 16S rRNA genes specific oligo-nucleotides. 
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RESULTS 
Table -1 
Demographic Profile of Study Population 
 
AGE MALE FEMALE TOTAL PERCENTAGE
20-29 7 2 9 6.9 
30-39 23 8 31 23.8 
40-49 32 12 44 33.8 
50-59 26 7 33 25.3 
>60 10 3 13 10 
TOTAL 98 32 130 100 
 
Out of a total of 130 cases 98 were male (75.38%) and 32 were 
(female24.62%). 
Chart -1 
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Table -2 
Symptoms and Sex Distribution In Relation To Clinical Diagnosis 
 
 
SYMPTOMS 
Gastric Carcinoma 
(n=19) 
Acid-peptic disease 
(n=111) 
Male Female % Male Female % 
Epigastric pain 14 2 84 79 18 87 
Vomiting 11 2 68 46 12 52 
Dyspepsia 6 1 37 69 20 80 
Loss of appetite 12 2 74 12 9 19 
Weight loss 11 3 74 15 18 30 
Haematemesis 6 1 37 8 3 10 
Malena 5 1 32 4 1 5 
 
Epigastric pain was the predominant symptom among patients with both 
acid peptic disease and gastric carcinoma. 
Chart -2 
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Table -3 
Categorization of the study population based on   
Endoscopic diagnosis 
 
Endoscopic diagnosis Total Percentage 
Duodenal Ulcer 49 38% 
Gastritis 44 34% 
Gastric ulcer 18 14% 
Gastric Carcinoma 19 15% 
Total 130 100% 
 
 Shows that 49 patients had duodenal ulcer, 44 cases had gastritis, 18 
cases had gastric ulcer and 19 cases had gastric carcinoma. 
Chart- 3 
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Table – 4 
 Rapid Urease Positivity vs Endoscopic diagnosis 
Endoscopic diagnosis Total Positive 
Duodenal Ulcer 49 23 
Gastritis 44 20 
Gastric ulcer 18 4 
Gastric Carcinoma 19 6 
Total 130 53 
 
41% of the cases (n=130) were positive by rapid urease test. 
Chart - 4 
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Table -5 
Time taken for Rapid Urease to become  positive 
Time taken in 
minutes 
No. of samples 
positive 
Percentage 
0-5 21 40% 
5-10 13 25% 
10-15 10 19% 
15-20 7 13% 
20-120 2 4% 
Total 53 41%- 
 
 Maximum colour change was detected in the first 5 minutes 
Chart - 5 
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Table -6 
 Positivity of H pylori by Gram stain 
Endoscopic diagnosis No of cases Positive Percentage 
Duodenal Ulcer 49 20 41% 
Gastric Ulcer 18 3 17% 
Gastritis  44 14 38% 
Gastric Carcinoma 19 5 26% 
Total 130 42 32% 
 
32% of of H.pylori infection was detected by Gram stain 
Chart - 6 
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Table -7 
Distribution of Giemsa positivity in the Endoscopic Diagnosis 
Endoscopic diagnosis No of cases Positive Percentage 
Duodenal Ulcer 49 23 47% 
Gastric Ulcer 18 4 22% 
Gastritis 44 19 43% 
Gastric Carcinoma 19 5 26% 
Total 130 51 39% 
 
Giemsa staining was positive in 40% of the cases. 
Chart - 7 
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Table -8 
 Comparison of urease with H pylori positivity in Gram stain,  
Giemsa stain and Histopathology 
 Clinical status 
No of 
cases 
RUT Giemsa Gram HPE 
Duodenal Ulcer 49 23 23 20 12 
Gastric Ulcer  18 4 4 3 3 
Gastritis  44 20 19 14 8 
Gastric Carcinoma  19 6 5 5 0 
Total  130 53 51 42 23 
 
Rapid urease and Giemsa gave comparable results 
Chart - 8 
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Table -9 
Detection of H pylori by culture 
Culture Total no. cases Percentage 
POSITIVE 23 18% 
NEGATIVE 107 82% 
TOTAL 130 100% 
 
18% of the cases were positive by culture 
Chart - 9 
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Table -10 
ELISA reading with Endoscopic diagnosis 
Endoscopic 
diagnosis 
No of cases
Range 
EU/ml 
Positive Percentage 
Duodenal Ulcer  49 12-198 44 90% 
Gastric Ulcer  18 8-154 2 11% 
Gastritis  44 10-186 31 70% 
Gastric Carcinoma  19 6-152 5 26% 
Total 130 - 82 63% 
 
Seroprevalence in the study population was 63%  
Chart - 10 
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Table -11 
 
Comparative evaluation of conventional methods and 
ELISA based IgG antibody detection 
 
 
Type of Test 
Patients (n=130) 
Positive Percentage 
Rapid Urease 53 41% 
Giemsa Staining 51 39% 
Gram Staining 41 32% 
Culture 23 18% 
Significant IgG titres (22u/mL) 82 63% 
 
Serology detected more cases than conventional tests 
Chart - 11 
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Table -12 
 Correlation of Immunochromotography with ELISA 
         n=130 
Name of Test Positive Percentage 
Immunochromotography 79 61% 
ELISA 82 63% 
 
ELISA was positive 82 in cases where as immunochromotography was 
positive in 79 cases 
Chart - 12 
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Table -13 
 PCR positivity (16S rRNA gene) in different types of  
Endoscopic diagnosis 
 
 
Endoscopic diagnosis  No. Of Cases Positive Percentage 
Duodenal Ulcer  27 19 70% 
Gastric Ulcer  4 1 25% 
Gastritis  17 11 65% 
Gastric Carcinoma  2 0 0% 
Total 50 31 62% 
 
PCR was positive in70% of the duodenal ulcer cases, 65% of gastritis 
cases, and 25% of gastric ulcer cases. 
Chart - 13 
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Table -14 
Correlation of PCR with Combination of Tests 
          n= 50 
RUT Gram 
stain 
Giemsa 
stain 
Culture PCR Total 
+ + + + + 8 
+ + - + + 1 
+ - + + + 2 
+ + + - + 8 
+ - + - + 5 
+ + - - + 2 
- - - - + 5 
- - - - - 19 
 
• PCR detected 5 cases which were negative by other conventional 
tests.  
• 8 cases were positive by RUT, Gram stain, Giemsa stain, Culture and 
PCR.  
• 1 case was positive by RUT, Gram stain, Culture and PCR.  
• 2 cases were positive by RUT, Giemsa stain, Culture and PCR.  
• 8 cases were positive by RUT, Giemsa stain and PCR.  
• 5 cases were positive by RUT, Giemsa stain and PCR.  
• 2 cases were positive by RUT, Gram stain and PCR.  
• 5 cases were positive by PCR.  
• 19 cases were negative. 
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Table -15 
 Correlation of PCR with Conventional test in 
50 samples 
 
         n=50 
Test Positive Percentage 
PCR 31 62% 
Culture 11 22% 
RUT 26 52% 
Gram 19 38% 
Giemsa 23 46% 
 
PCR detected the maximum number of positive cases when compared to 
conventional tests. 
Chart - 15 
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Table -16 
 Correlation of PCR with Serology 
   n=50 
Name of Test  Positive Percentage 
PCR 31 62% 
ELISA 32 64% 
Immunochromotography 29 58% 
 
ELISA was positive in 64% of cases, PCR in 62%, 
Immunochromotography in 29 cases  
Chart - 16 
 
 
 59
DISCUSSION 
The present work is based on using conventional and molecular methods 
for detecting Helicobacter pylori infection. Four biopsy based tests namely 
rapid urease test, histolopathological examination, bacterial culture and PCR 
and two serological tests were used. The conclusions from the study give 
fruitful thought about the relative merits and demerits of each method.  
        A total of 130 patients with upper gastrointestinal symptoms were 
enrolled in the study. Among them 98 (75.38%) were males and 32 (24.6%) 
were females. (Table -1).  
The maximum number of patients in this study was in the age group 40-
49. In the study conducted by D.Nair et al79 out of the 136 patients, 116 were 
male and 20 were female is comparable to the present study which also showed 
males were more affected than females. 
 Among the patients with gastric carcinoma, epigastric pain was the 
presenting symptom in 84%, vomiting in 68%, loss of appetite and loss of 
weight in 74%, haematemesis in 37%, dyspepsia in 37% and malena accounted 
for 32% . 
Among the patients with peptic ulcer disease the predominant symptom 
was epigastric pain in 87% of cases, dyspepsia in 80%, vomiting in 52%, loss 
of weight in 30%, loss of appetite 19%, haematemesis in 10% and malena in 
5% of the cases.    
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       Epigastric pain was the predominant symptom among patients with acid 
peptic disease and gastric carcinoma. (Table -2). 
The endoscopic examination of the study population revealed that 
duodenal ulcer accounted for 38%, gastritis in 34%, gastric carcinoma in 15%, 
and gastric ulcer in 14%. (Table -3) 
 All of the 130 patients were subjected to Rapid urease test, Gram 
staining, Geimsa Staining, Histopathology, Culture and Serology. PCR was 
performed on 50 cases which included 27 patients with duodenal ulcer, 17 with 
gastritis, 2 with gastric carcinoma and 4 with gastric ulcer. 
       Out of the 130 samples studied by Rapid urease test, 53 (41%) were 
positive (Table -4). The overall positivity of RUT correlated well with reports 
by Sivaprakash et al (38.7%)104, While it was lower than that reported by 
Maimooma et al (65.8%) 61. In the present study 96% of the cases were positive 
within the first 20 minutes (Table-5). This is comparable to 95% reported by 
Senguta et al103. Marshall et al using a CLO test   reported that 75% of the 
positive tests are detected within 20 minutes, 92% at 3 hour and 98% at 24 
hours64. The present study showed more rapid change probably due to omission 
of buffer. 
The direct Gram stained smears in our study showed positivity in 32% 
which is comparable to the study by U.Arora et al9. While Anjana et al reported 
72.3%8 . Other studies report values, ranging between 44-74% 61, 77 (Table6). 
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          In the present study Giemsa staining of the crushed smear was positive in 
39% of the smears studied. This correlates with the findings of 31% by 
Philip.E.Coudron et al94. (Table- 7). 
Histopathological examination by Haematoxylin and Eosin staining was 
positive in 23 cases whereas Giemsa showed 53 positive cases. Studies by 
Aarti et al1 and Madan et al 60 also report that Giemsa technique showed greater 
positivity than Haematoxylin and Eosin staining. (Table- 8). 
In the present study rapid urease detected 53 positive cases, Giemsa 
staining 51 cases, Grams staining 41 cases and Haematoxylin and Eosin 23 
cases. The present study shows that Giemsa and rapid urease tests are 
comparable.  
A similar picture emerges in the study by Anjana et al, in which 34 out 
of 47 cases were urease positive, while Giemsa was positive in 38 out of 47 of 
the cases. Culture positivity in the present study was 17.6%. U.Arora et al 
reported culture positivity of 28%. This low isolation rate may be due to the 
patchy distribution of H.pylori in gastric mucosa, its fastidious nature, mucosal 
atrophy9, intestinal metaplasia, administration of antibiotics[ to some other 
infections] and proton pump inhibitors39. (Table-9) 
The present study reveals that serology was positive in 82 out of the 130 
samples tested (63%) This is comparable to the study by D.Nair79 who reported 
a positive result in 64.9%.The distribution of positive serology results as 
against endoscopic findings in the study population is as follows- duodenal 
ulcer 44 cases, gastric ulcer 2 cases, gastritis 3 cases 1 cases and gastric 
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carcinoma 5 cases. Hence there exists a positive correlation between duodenal 
ulcer and H.pylori, confirming previous reports33. (Table-10)  
Serology showed a greater number of positive cases than the 
conventional tests which may be due to past infection. This is comparable to 
the study by U. Arora et al, who reported greater case detection by serology 
than by conventional tests. (Table-11) The patchy distribution of organism in 
the gastric mucosa may have resulted in a lower value for biopsy based test. 
Another factor could be the presence of gastric atrophy and intestinal 
metaplasia that are hostile to H.pylori90.    
The number of samples positive by ELISA was 82 as against 79 by 
immunochromatography.  (Table- 12) 
The study by R.J.F.Laheiji et al57 showed that the serology kits that 
measured all isotypes specific to H.pylori  did not perform as well as those that 
measured only IgG.This is comparable with the present study which used 
ELISA that detected IgG antibody and immunochromotographic test which 
detected all isotypes specific to H.pylori.    
Among the 50 samples subjected to PCR, it was positive in 31 cases. 
The distribution of positive cases among the clinical conditions is as follows - 
duodenal ulcer 27 cases, gastritis 17 cases, gastric ulcer 4cases and gastric 
carcinoma 2 cases. (Table -13) 
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PCR was positive in 62%, RUT In 52%, giemsa staining in 46%, Grams 
staining in 38% and culture22%. (Table-15). Thus PCR detected the most 
number of cases. 
PCR detected H.pylori in all 11 biopsy samples that were culture 
positive. Out of the 20 culture negative samples 15 were detected by 
conventional methods and PCR.  H.pylori in 5 samples were detected only by 
PCR .These  5 samples may be accounted for by the high sensitivity of this 
method or may have contained low number of viable cells and hence could not 
have been detected by routine diagnostic tests. Alternatively, the PCR assay 
may have detected the controversial “resting form “of the bacterium16, a 
proposed phase into which the vegetative form of the bacterium might 
differentiate under conditions of environmental stress. Clayton et al in his study 
reported that 7 out of 23 samples positive by PCR were negative by 
conventional tests. 
All cases detected by PCR were also seropositive except one sample was 
negative by PCR, but positive by serology. It is possible that in this type of 
patient the ELISA detects a long lived antibody response. To H.pylori antigens 
well after an active infection has ceased. This is comparable to the study 
conducted by Marten Hammaret et al69 in which three samples positive by 
serology were negative by PCR.  
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SUMMARY 
1.  The majority of cases, out of a study population of 130 patients, were in 
the age group of 40-49 years. 
2. A preponderance of males was noted among the study population. 
3. Epigastric pain was the most common symptom in both gastric 
carcinoma and acid peptic disease. 
4. Duodenal ulcer was the commonest endoscopic finding observed during 
the course of the study.  
5. Rapid urease test was positive in 41% of the samples, 64.15% of which 
were positive in the first 10 minutes. 
6. Gram stain was positive in 32% of the cases. 
7. Giemsa stain was positive in 39% of the cases. 
8. More number of samples was found to be positive for H.pylori by 
Giemsa stain (39%) as compared to those prepared by Gram stain (32%)  
9. Culture for H. pylori was positive in only 18% of the cases. 
10. The Seroprevalence of the study population was 63%. 
11. ELISA based IgG antibody detected more positive cases than the 
conventional methods. (63% vs. 41%) 
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12. ELISA test detected more positive cases than immunochromotography 
test. (63% vs.  60%) 
13. PCR which was positive in 62% of the study population detected more 
number of positive cases than by conventional methods. (62% vs. 52%). 
14. Serology was positive in 64% of the cases as compared to 62% which 
were positive by PCR.  
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CONCLUSION 
  A preponderance of H.pylori infection was noted in patients with 
duodenal ulcer.  
 The simple and inexpensive Rapid urea test detected the 
maximum number of positive cases among the conventional tests. 
Hence it is a valuable adjunct to endoscopy. 
  ELISA detected a significant number of H.pylori cases as 
compared to conventional methods however; the levels of 
H.pylori specific antibodies must be evaluated in the normal 
population to establish ELISA as a definitive diagnostic tool. 
 ELISA is preferred to rapid test for the detection of H.pylori 
when facilities for Elisa are available. 
 Isolation of organisms is feasible only in reference laboratories. 
 PCR amplification of H.pylori DNA sequences has the potential 
to be a highly sensitive method for the laboratory diagnosis of 
H.pylori infection. 
PROFORMA 
 
Name     :   Occupation :  Age/Sex : 
 
Income  :   Address       :          O.P/I.P. No.    : 
 
Unit       :                                Date  : 
 
H/O. PRESENT ILLNESS 
 
Epigastric Pain : Vomiting/Nausea : Dyspepsia    : 
 
Haematemesis         :  Malena  : loss of weight  : 
Loss of appetite : Others   : 
 
PERSONAL HISTORY 
 
Alcohol :    Smoking :                  h/o drug intake : 
 
Diet Habits :             Previous h/o Gastric surgery : 
 
GENERAL EXAMINATION 
 
Consciousness :   Built :   Nourishment : 
 
Pallor :           Jaundice :  Cyanosis : 
 
Clubbing :    Pedal Edema :              Lymphadenopathy : 
 
Pulse :     BP :   Respiratory Rate : 
 
Temperature : 
 
SYSTEMIC EXAMINATION 
 
Abd   :  Other systems    :  
INVESTIGATIONS  : 
UGI Scopy  :  USG Abd     :  
 
Rapid Urease  :  Grams stain      : 
 
Giemsa stain  :  Histopathology     : 
 
Culture  :  Serology       : 
                                                   
PCR                         : 
APPENDIX 
 
1. Urea Broth  
 
Stock Solution A [1% phenol red solution (free acid)] 
 
1ml of phenol red was dissolved in 32.5 ml of 0.1 mol/L sodium hydroxide and 
made upto 100 ml distilled water.  The solution was autoclaved for 15 minutes at 
121oC. 
Stock solution B ( 8% urea solution) 
8gm of urea was dissolved in 100 ml of sterile distilled water under sterile 
precautions.  The pH of the solution was adjusted to 6.8, and dispensed in 0.5 mL 
aliquots in sterile vials. 
Two drops of 1% phenol red was added to each vial containing 0.5mL of 8% urea 
solution. 
2. Chocolate Agar 
Peptone     :  1.0 gm 
Meat Extract              :     1.0 gm 
Sodium chloride    : 0.5 gm 
Agar agar    : 2 gm 
Distilled water    : 100 mL 
Defibrinated sheep blood            :     10% 
3. Skirrow’s Campylobacter Medium 
I. Campylobacter agar base : 39.5 gm 
II. Distilled water   : 1 litre 
III. Skirrow’s supplement  : 1 vial consisting of 
 Vancomycin   :  10 mg 
 Polymyxin B   :   2500  IU 
 Trimethoprim   : 50 mL 
Sheep blood was used as horse blood was not available. 
Amphoterecin B 5 mg/L and 10% defibrinated sheep blood was used. 
    
4. Phosphate Buffered Saline[PBS] 
Ingredients                                                                        grams/ litre 
Sodium chloride                                                               8.0 
Potassium chloride                                                          0.2 
Disodium hydrogen phosphate                                        1.15 
Potassium dihydrogen phosphate                                    0.2 
Distilled water                                                                   1000ml 
pH was adjusted to 7.4 
The above ingredients were dissolved in sterile distilled water and then filtered using 
filter paper. 
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